Insights On Outsourced Drug Development

  1. Advancement Of Upstream Bioprocess Intensification 7/1/2025

    Explore how two companies unite to streamline upstream process intensification with integrative technology to boost efficiency, scalability, and innovation in biopharmaceutical manufacturing.

  2. Protecting Human Health With Organ-On-A-Chip Technology 3/1/2024

    Explore compelling evidence that suggests Organ-on-a-Chip technology offers a far more reliable means of predicting drug toxicity than traditional animal models.

  3. Duodenum Intestine-Chip For Modeling Human Physiology 3/14/2024

    Discover an Intestine-Chip that integrates the robust cell sourcing of organoids with Organs-on-Chips technology to overcome experimental limitations and yield a closer-to-human transcriptomic profile.

  4. Boosting In Vitro Toxicology Testing With Organ-Chips 4/9/2024

    Discover how Organ-Chips are enhancing preclinical testing, minimizing toxicity issues, and streamlining clinical trials for enhanced safety and efficiency.

  5. Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems 4/4/2025

    For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.

  6. MAPK Signaling Pathway 4/7/2025

    Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

  7. API Solubility And Dissolution Enhancement Via Formulation 6/4/2025

    Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.

  8. Developing A Quantitative Surrogate Peptide Assay 7/17/2025

    Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

  9. Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed 9/17/2024

    Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

  10. An All-In-One Solution For Residual DNA Quantitation 5/22/2025

    Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.